Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables.
Por:
Silva-Díaz M, Blanco FJ, Quevedo Vila V, Seoane-Mato D, Pérez-Ruiz F, Juan-Mas A, Pego-Reigosa JM, Narváez J, Quilis N, Cortés R, Romero Pérez A, Fábregas Canales D, Font Gayá T, Bordoy Ferrer C, Prado-Galbarro FJ, Sánchez-Piedra C, Díaz-González F and Bustabad-Reyes S
Publicada:
1 jun 2022
Ahead of Print:
10 nov 2021
Resumen:
OBJECTIVE: Axial osteoarthritis (OA) is a common cause of back and neck pain, however, few studies have examined its prevalence. The aim was to estimate the prevalence and the characteristics of symptomatic axial OA in Spain. METHODS: EPISER2016 is a cross-sectional multicenter population-based study of people aged 40 years or older. Subjects were randomly selected using multistage stratified cluster sampling. Participants were contacted by telephone to complete rheumatic disease screening questionnaires. Two phenotypes were analyzed, patients with Non-exclusive axial OA (NEA-OA) and Exclusive axial OA (EA-OA). To calculate the prevalence and its 95% confidence interval (CI), the sample design was considered and weighting was calculated according to age, sex and geographic origin. RESULTS: Prevalence of NEA-OA by clinical or clinical-radiographic criteria was 19.17% (95% CI: 17.82-20.59). The frequency of NEA-OA increased with age (being 3.6 times more likely in patients aged 80 s or more than in those between 40 and 49 years) and body mass index. It was significantly more frequent in women, as well as in the center of Spain. It was less frequent in those with a higher level of education. Lumbar OA was more frequent than cervical OA. This difference grew with increasing age and was not associated with gender. It was also greater in overweight and obese subjects. CONCLUSIONS: This is the first study on the prevalence of axial OA phenotypes in Europe describing the associated socio-demographic, anthropometric, and lifestyle variables.
Filiaciones:
Silva-Díaz M:
Unidad de Investigación Clínica, Grupo de Investigación de Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña, A Coruña, Spain
Blanco FJ:
Unidad de Investigación Clínica, Grupo de Investigación de Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña, A Coruña, Spain.
Universidade da Coruña (UDC), Grupo de Investigación de Reumatología y Salud (GIR-S). Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Fisioterapia,, Campus de Oza, A Coruña, España.
Quevedo Vila V:
Rheumatology Unit, Hospital Comarcal Monforte de Lemos, Monforte de Lemos, Lugo, España
Seoane-Mato D:
Research Unit, Spanish Society of Rheumatology, Madrid, España
Pérez-Ruiz F:
Rheumatology Department, Hospital Universitario Cruces, Baracaldo, Vizcaya, España
Juan-Mas A:
Rheumatology Department, Hospital Son LLàtzer, Palma de Mallorca, Baleares, España
Pego-Reigosa JM:
Rheumatology Department, Complejo Hospitalario Universitario de Vigo, Grupo IRIDIS, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Vigo, Pontevedra, España
Narváez J:
Rheumatology Department, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España
:
Rheumatology Department, Hospital General Universitario de Elda, Elda, Alicante, España
Cortés R:
Rheumatology Department, Hospital General de Ontinyent, Ontinyent, Valencia, España
Romero Pérez A:
Rheumatology Department, Complejo Hospitalario de Jaén, Jaén, España
Fábregas Canales D:
Rheumatology Department, Hospital de Barbastro, Barbastro, Huesca, España
Font Gayá T:
Rheumatology Department, Hospital Comarcal de Inca, Inca, Baleares, España
Bordoy Ferrer C:
Rheumatology Department, Hospital Comarcal de Inca, Inca, Baleares, España
Prado-Galbarro FJ:
Orphan Drug Laboratory, Biologic System Department, Metropolitan Autonomous University, Mexico City, Mexico
Sánchez-Piedra C:
Research Unit, Spanish Society of Rheumatology, Madrid, España
Díaz-González F:
Department of Internal Medicine, Dermatology and Psyquiatry, Universidad de La Laguna, La Laguna, Santa Cruz de Tenerife, España
Rheumatology Department, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, España
Bustabad-Reyes S:
Rheumatology Department, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, España
Open Access
FULL TEXT
 |
Published Version |
|
| No Accesible |
|